Bond.az White LogoBond.az Black Logo

Aquila Renewables: Adviser Withholds Fee Data

Aquila European Renewables says its investment adviser Aquila Capital has not provided complete fee information. The Board is considering legal action.

Sebastian Young
BySebastian Young- Senior Editor
|
0

LONDON - Aquila European Renewables plc (LSE:AERW) said Monday that its investment adviser, Aquila Capital Investmentgesellschaft mbH, has not provided complete information on fees and charges related to the company’s portfolio.

The Board first requested the information on December 4, 2025, and repeated the request in writing on February 6, 2026, according to a press release statement. Aquila Capital is a wholly owned subsidiary of Commerzbank Group.

The requested information includes disclosure of all fees, charges and expenses borne by the company or its subsidiaries, amounts paid to Aquila Capital or related entities, development profits or other economic benefits connected with acquired assets, and ownership information on portfolio acquisition structures.

Aquila Capital responded on February 17, 2026, stating it was reviewing general ledgers and that certain payments were likely related to travel cost recharges, power price curve costs and domiciliation services. The adviser has not provided complete schedules, supporting agreements, invoices or ownership information requested by the Board.

The Board said Aquila Capital’s response addressed only benefits paid after the company became a shareholder in relevant special purpose vehicles. The Board’s request includes profits or economic benefits accruing to Aquila Capital or connected parties before the company’s acquisition of assets.

The company has incurred legal costs of approximately £160,000 related to an unsuccessful proposed sale to Aquila Capital of approximately half of the company’s portfolio, announced on May 14, 2026. The Board intends to request that Aquila Capital waive investment advisory fees equal to these costs.

Chairman Robert Naylor said the Board expects Aquila Capital, its Supervisory Board and Commerzbank Group to provide the requested information without further delay. The Board said it continues to explore available remedies and will consider action to protect shareholder interests.

More News
Today / 08:31
|
889

Causeway Capital Boosts Melrose Stake to 5.12%

Causeway Capital increased its stake in Melrose Industries to 5.12%. The investment firm now holds over 63 million voting rights.

0
Today / 08:03
|
968

Ignitis grupė starts search for new CEO

Ignitis grupė launches CEO search in Lithuania. Learn about requirements and application deadline for the new CEO position.

0
Today / 07:31
|
226

USA Rare Earth Plans €175M France Investment

USA Rare Earth reveals €175 million investment plan in France for metal, alloy and magnet manufacturing, aiming to create over 300 jobs by 2030.

0
Today / 07:30
|
761

Lucid Group Names Silvio Napoli CEO

Lucid Group appoints Silvio Napoli as CEO effective immediately. Stock up 12% in past week but down 38% YTD. Company faces financial challenges.

0
Today / 07:04
|
679

Mkango Reports Q1 2026 Financial Results

Mkango Resources reports Q1 2026 financial results. Details on rare earth projects, recycling operations, and SPAC merger.

0
Today / 07:02
|
274

Greatland secures $500m debt facility, OKs Havieron

Greatland Resources secures $500 million corporate debt facility and board approval for Havieron gold-copper project final investment decision.

0
Today / 07:00
|
542

Calnex director buys shares at 69.9p

Calnex Solutions non-executive director Graeme Bissett buys 28,610 shares at 69.9p each on the London Stock Exchange.

0
Today / 06:34
|
619

Redcentric Appoints Tim Sykes as CFO

Redcentric appoints Tim Sykes as CFO. With 30+ years of experience, Sykes will drive growth in the MSP business.

0
Today / 06:31
|
250

Invinity sells 2 MWh battery for Wisconsin

Invinity Energy Systems sells a 2 MWh vanadium flow battery for a DOE-funded project in Wisconsin.

0
Today / 06:30
|
729

CRISM Secures £99,902 Grant for Cancer

CRISM Therapeutics receives £99,902 grant from Invest NI for docetaxel-ChemoSeed prostate cancer program development.

0
Today / 06:01
|
767

Jyske Bank buys back 50.3m kroner shares in week 22

Jyske Bank repurchased 49,625 shares worth 50.3 million kroner in week 22 of 2026. The buyback program has a total value of up to 3 billion kroner.

0
Today / 06:00
|
290

Sinch Appoints Sophie Cheng as CMO

Sinch AB appoints Sophie Cheng as Chief Marketing Officer. Details on leadership change, stock performance, and CEO transition.

0
...
Aquila Renewables: Adviser Withholds Fee Data | Bond.az